Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
Unit dosing of darbepoetin alfa for thetreatment of anemia in patients with end-stage renal disease being switched from recombinant human erythropoietin: Results of a phase IIIb, 27-week, multicenter, open-label study in Greek patients. [electronic resource] by
- Bristoyiannis, Georgios
- Germanos, Nikolaos
- Grekas, Dimitrios
- Hatzidimitriou, Christos
- Iatrou, Christos
- Memmos, Dimitrios
- Moutafis, Spiros
- Papachristoforou, Konstantinos
- Papadoniou, Antonis
- Pappas, Michalis
- Sakellariou, George A
- Siamopoulos, Kostas C
- Sombolos, Konstantinos
- Stamatelou, Kiriaki
- Stathakis, Charalambos P
- Stavgiannoudakis, Georgios
- Stratigis, Spiros
- Syrganis, Christos
- Tsakiris, Dimitris
- Valis, Dimitris
- Vlahojannis, Jannis G
- Vlassopoulos, Dimosthenis
Producer: 20140327
In:
Current therapeutic research, clinical and experimental vol. 66
Availability: No items available.
|